Sat - Sun: Closed
Title Image

Celebrating 44th Birthday, Pyridam Farma Changes Logo

Celebrating 44th Birthday, Pyridam Farma Changes Logo

Jakarta, December 2, 2020. The pharmaceutical company PT Pyridam Farma Tbk. (The “Company” or “Pyridam Farma”), which became an issuer on the stock exchange with the code PYFA, made a transformation by changing the company logo to coincide with the Company’s 44th anniversary on Friday, November 27, 2020. As a pharmaceutical company listed on the Stock Exchange Indonesia, we have made an official announcement to all stakeholders, especially the Indonesia Stock Exchange, the Financial Services Authority, and the public.
“The company’s transformation in the form of changing the logo shows that Pyridam Farma has a new, more innovative and modern spirit, especially in terms of the products it sells. This logo change step is one example of the many Pyridam Farma transformations to improve company performance. going forward, “this was stated by Yen Gunadi, Director of the Pyridam Farma Company, in a press release on Tuesday, December 2, 2020.

Yen Gunadi added that the company intends to change the company logo to keep up with the times by instilling a more modern identity so that it is always adaptive to developments in the world of health and the needs of society.
Inspired to become a more modern and innovative pharmaceutical company, this new logo applies a more futuristic color and design while maintaining the Pyramid as the main symbol of the Company which means Eternal or Eternal. Blue and purple are used to symbolize modern, peaceful (peaceful) and trust.
“We hope that this logo change can give new enthusiasm and confidence to Pyridam Farma and also all stakeholders, including shareholders, employees and partners, and also reflects Pyridam Farma’s new vision to become a more modern, innovative, moving company. developing and also at the forefront of providing health solutions to the community, “added Yen Gunadi.

At the age of 44, the Company’s business development continues to experience a significant increase and hopes that it will continue to increase in the future by keeping abreast of developments in the health sector, especially in relation to Covid-19 at this time. One of the things that has been done is to provide a Mobile PCR Lab and also to continue to develop products such as supplements and immune-boosting vitamins, such as Vitamin Damuvit C 1000 and Vitamin D3-1000 as well as products related to the prevention and treatment of Covid-19. Consumers can now get PYFA products easily through the official sales website or in various well-known market places in the country.

In the future, the Company has strategic plans to continue to increase the pace of the company, including by continuing to develop medicinal products that are more relevant to the needs of society and also medicinal products that are classified as innovative and pioneering in their own production or in partnership with international pharmaceutical companies. . One of the innovative products that we have marketed since the third quarter yesterday, for example, Syalox 300 P, the first oral Hyaluronic Acid innovator in Indonesia, is made in the form of triple layer tablets with patented technology from Italy, for solutions to relieve joint pain or swelling, injection replacement / injection therapy.

As previously reported, the Company previously signed a memorandum of understanding or memorandum of understanding with an Australian pharmaceutical company, Vaxine Pty Ltd regarding the commercialization of the Covid-19 vaccine candidate. The memorandum of understanding was signed on October 12, 2020. The vaccine candidate being developed by Vaxine is Covax-19. Currently, Covax-19 is undergoing phase 1 trials in Australia.
The company also has a subsidiary based in Singapore under the name Pyfa Health Singapore Pte. Ltd. which is engaged in the business of research companies and experimental development of biotechnology, life sciences and medical sciences (experimental development of biotechnology, life, and medical science).

About PT Pyridam Farma Tbk.

PT Pyridam Farma Tbk is a pharmaceutical company whose main business is the production and / or distribution of modern and traditional medicines as well as the distribution of medical devices such as laboratory equipment as well as PCR test kits. The company was founded in 1976 and has been a public company and has been listed on the Indonesia Stock Exchange since 2001.
PT Pyridam Farma Tbk. manufactures a wide range of pharmaceutical products such as Antibiotics, Vitamins, Supplements, and Traditional Herbal Treatments. The company has more than 200 products in the form of tablets, caplets, capsules, cream syrups and ointments. In addition, PT Pyridam Farma Tbk. also manufactures prescription products such as penicillin and non-penicillin antibiotics, and painkillers, as well as pros